EUROPEAN UNION 1997 SEAFOOD-SAFETY BAN: THE ECONOMIC IMPACT ON BANGLADESH SHRIMP PROCESSING

Major markets for Bangladesh frozen shrimp are the European Union, the United States, and Japan. Bangladesh frozen shrimp imports into the EU and the United States have experienced safety and quality problems. The 1997 European Commission ban on Bangladesh seafood imports into the EU cost the Bangladesh frozen shrimp processing industry US$14.665 million in lost revenues.Resource /Energy Economics and Policy,

On the Computational Complexity of the Strong Geodetic Recognition Problem

A strong geodetic set of a graph~$G=(V,E)$ is a vertex set~$S \subseteq V(G)$ in which it is possible to cover all the remaining vertices of~$V(G) \setminus S$ by assigning a unique shortest path between each vertex pair of~$S$. In the Strong Geodetic problem (SG) a graph~$G$ and a positive integer~$k$ are given as input and one has to decide whether~$G$ has a strong geodetic set of cardinality at most~$k$. This problem is known to be NP-hard for general graphs. In this work we introduce the Strong Geodetic Recognition problem (SGR), which consists in determining whether even a given vertex set~$S \subseteq V(G)$ is strong geodetic. We demonstrate that this version is NP-complete. We investigate and compare the computational complexity of both decision problems restricted to some graph classes, deriving polynomial-time algorithms, NP-completeness proofs, and initial parameterized complexity results, including an answer to an open question in the literature for the complexity of SG for chordal graphs

Depression and anxiety in patients with multiple sclerosis treated with interferon-beta or fingolimod : role of indoleamine 2,3-dioxygenase and pro-inflammatory cytokines

Depression/anxiety (D/A) occurs in up to 50% of multiple sclerosis (MS) patients. Proinflammatory cytokines induce classical symptoms of depression. Activation of the inflammatory response also triggers production of indoleamine 2,3-dioxygenase (IDO), which catabolizes tryptophan, the amino acid precursor of serotonin and melatonin. It has been suggested that IDO is the link between the immune and serotonergic systems. This study aimed to quantify the levels of IDO and pro-inflammatory and anti-inflammatory cytokines in patients with MS and depression, according to treatment with interferon-beta (IFN-β) or fingolimod. The study inclusion criteria were age 18–60 years and a clinical and radiological diagnosis of MS. One hundred and thirtytwo patients diagnosed by McDonald’s criteria and followed up at Brasília District Hospital, Brazil, with relapsingremitting MS were identified as potential study participants. Thirty-five of these patients were identified to be receiving treatment with fingolimod or IFN-β and to have a diagnosis of D/A. IDO and pro-inflammatory and antiinflammatory cytokine levels were compared between these 35 patients and 18 healthy controls. The level of IL10 (an anti-inflammatory cytokine) was lower in both the fingolimod-treated (P < 0.001) and IFN-β-treated (P < 0.01) patient groups than in the control group. IFN-β-treated patients showed increased IDO expression and decreased inflammatory cytokine levels. In contrast, fingolimod-treated patients showed significantly decreased expression of IDO and significantly increased levels of proinflammatory cytokines produced by innate immune cells, including tumor necrosis factor-alpha and interleukin-6. The agents used to treat MS maintain symptoms of D/A in patients with MS via different mechanisms

Evolução na utilização e nos gastos de uma operadora de saúde

Brazil’s aging population and the rising number of people reliant upon the country’s supplementary healthcare system have elicited the concern of public and private managers regarding the increase in healthcare costs. In this paper, the costs per gender, per type of medical expenses and per age group of a major Brazilian self-managed healthcare provider between 2007 and 2013 were analyzed. This healthcare provider is of interest because, besides portraying a single condition of revenue growth restricted to the existing contributors, it also replicates the demographic profile expected for Brazil in 2050, when approximately one-third of its population will be over 60 years of age. The analyses confirm the current literature as they show an increase in healthcare plan usage by the elderly and the difference between admission rates by gender. They also reveal an increase in average length of stay in hospital and the increase in medical costs far above inflation, especially for materials and medicines. It is hoped that this study will help scholars and others interested in comparisons of medical expense trends, especially by age and sex, and that it encourages further collaboration on the sustainability of health insurance providers in Brazil